Superworth

Vontier price to free cash flow VNT

Market value divided by free cash flow over the last twelve months, since 2021.

Today, Nov 2, 2026
12.9×
5-year median
13.3×
Against its 5-year history
43rd
percentile: 0 is its lowest day, 100 its highest
5-year range
8.1× to 17.7×
Peer median
25.7×

Vontier's price to free cash flow is 12.9× as of Nov 2, 2026.

That is below its 5-year median of 13.3×, close to the middle of its last 5 years.

Over that time it ranged from 8.1× in Feb 2022 to 17.7× in Mar 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 25.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far12.9×10.6×14.7×
202513.4×12.2×16.9×
202415.9×12.6×17.7×
202313.0×12.1×17.0×
202213.8×8.1×14.7×
202110.2×9.0×11.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Vontier's size, closest first, today.

CompanyPrice to free cash flow
VNTVontier12.9×
MMSIMerit Medical Systems24.8×
HAEHaemonetics18.8×
BMIBadger Meter31.6×
ICUIICU Medical26.6×
NVSTEnvista16.0×
MSAMSA Safety20.3×
ATRCAtriCure57.3×
WRBYWarby Parker136×
PODDInsulet36.3×
GMEDGlobus Medical14.1×
Peer median25.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Vontier

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.